Fulgent Genetics, Inc. (FLGT) vs NeoGenomics, Inc. (NEO)
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
- NeoGenomics, Inc. NEO 16.65 −3.48%
Fulgent Genetics, Inc. and NeoGenomics, Inc. are both Diagnostics & Research companies. NeoGenomics, Inc. is the larger, with a market value of $2.2B against $587.2M — 3.8× the size. NeoGenomics, Inc. grew revenue faster over the last twelve months: 11.2% against 6.83%. NeoGenomics, Inc. has the higher net margin (−6.77% vs −26.1%) and the higher return on invested capital (−4.20% vs −10.3%). Across the 18 metrics below, NeoGenomics, Inc. leads on 13 and Fulgent Genetics, Inc. on 5.
Valuation
Profitability
| Metric | FLGT | NEO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 43.92% | 50.89% |
| Operating margin | (37.75%) | (8.93%) | (8.57%) |
| Net margin | (26.05%) | (6.77%) | (6.37%) |
| Free cash flow margin | (32.04%) | (0.69%) | 0.00% |
| Return on equity | (8.01%) | (6.33%) | (2.92%) |
| Return on assets | (7.37%) | (3.78%) | (6.71%) |
| Return on invested capital | (10.34%) | (4.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack